Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hearing losses
ADR ID BADD_A01157
ADR Hierarchy
04      Ear and labyrinth disorders
04.02      Hearing disorders
04.02.01      Hearing losses
Description Not Available
MedDRA Code 10011879
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02031Sitaxentan--
BADD_D02038Sodium ferric gluconate complex--
BADD_D02047Sodium oxybate0.000671%
BADD_D02058Sorafenib0.000638%
BADD_D02066Spironolactone0.000183%
BADD_D02071Streptomycin--
BADD_D02072Streptomycin sulfate--
BADD_D02093Sulfasalazine--
BADD_D02097Sulindac--
BADD_D02098Sumatriptan--
BADD_D02099Sumatriptan succinate--
BADD_D02100Sunitinib0.000504%
BADD_D02104Tacrine hydrochloride--
BADD_D02105Tacrolimus0.001782%
BADD_D02106Tadalafil0.005348%
BADD_D02107Tafamidis0.012005%
BADD_D02118Tasimelteon0.000131%
BADD_D02141Teichomycin--
BADD_D02143Telavancin--
BADD_D02147Telmisartan0.000521%
BADD_D02150Temozolomide0.000280%
BADD_D02154Tenofovir0.009112%
BADD_D02160Terbinafine0.001221%
BADD_D02161Terbinafine hydrochloride--
BADD_D02170Testosterone--
BADD_D02171Testosterone cypionate0.001048%
BADD_D02172Testosterone enanthate-
BADD_D02174Testosterone undecanoate--
BADD_D02179Tetracycline--
BADD_D02192Thalidomide0.003110%
The 14th Page    First    Pre   14 15 16 17    Next   Last    Total 17 Pages
ADReCS-Target
ADR Term Drug Name Target